Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 3

Mucous membrane pemphigoid: A wide-ranging assessment of various cases and corresponding methods of diagnosis and treatment

Pages
713–719
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose this article is to bring light to the dental community, medical professionals and autoimmune disease researchers, the importance of an early and authentic diagnosis and corresponding methods of recent treatments.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mucous Membrane Pemphigoid (MMP) is as an infrequent yet tenacious autoimmune blistering disease involving the mucosae of the oral cavity, as well as the conjunctiva, genitals, nasal cavity, pharynx and occasionally the skin.
📊
Key Findings & Data:It is seen most commonly in older adults, although cases have been reported throughout early childhood.
💡
Conclusion & Impact:The purpose this article is to bring light to the dental community, medical professionals and autoimmune disease researchers, the importance of an early and authentic diagnosis and corresponding methods of recent treatments.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Mucous Membrane Pemphigoid (MMP) is as an infrequent yet tenacious autoimmune blistering disease involving the mucosae of the oral cavity, as well as the conjunctiva, genitals, nasal cavity, pharynx and occasionally the skin. It is seen most commonly in older adults, although cases have been reported throughout early childhood. This review article will provide a thorough explanation of MMP by discussing common misdiagnosis scenarios, presenting rare case reports, and exploring recent treatment options in hopes of spreading awareness for furthering research on diagnosis techniques. The purpose this article is to bring light to the dental community, medical professionals and autoimmune disease researchers, the importance of an early and authentic diagnosis and corresponding methods of recent treatments.

🔖

Cite This Article

SİVRİ, Z. F., CHANDRA, S. B. (2018). Mucous membrane pemphigoid: A wide-ranging assessment of various cases and corresponding methods of diagnosis and treatment. Medicine Science, Cilt: 7 - Sayı: 3, 713–719. https://ajindex.com/articles/277243

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Beruschi, MP. Mucous membrane pemphigoid: our 14 years’ experience. Dermatologia revista edicion ingles, 2009;82-8.
  2. Kanwar A, Koga H, Vinay K, et al. Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: First report from India. Indian J Dermatol Venereol Leprol. 2012;78:475-9. Chan LS. Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid). Clin Dermatol. 2012;30:34-7.
  3. Scully C, Lo Muzio L. Oral mucosal diseases: Mucous membrane pemphigoid. Br J Oral Maxillofac Surg. 2008;46:358-66.
  4. Vijayan V, Paul A, Babu K, et al. Desquamative gingivitis as only presenting sign of mucous membrane pemphigoid. J Indian Soc Periodontol. 2016;20:340-3.
  5. Murono S, Nakanishi Y, Fujimoto M, et al. Hypopharyngeal presentation of cicatricial pemphigoid: video-fluorographic and direct laryngoscopic findings. J Laryngol Otol. 2013;127:429-31.
  6. Srikumaran D, Akpek EK. Mucous membrane pemphigoid: recent advances. Curr Opin Ophthalmol. 2012;23:523-7.
  7. Challacombe SJ, Setterfield J, Shirlaw P, et al. Immunodiagnosis of pemphigus and mucous membrane pemphigoid. Acta Odontol Scand. 2001;59:226-34.
  8. Takahara M, Tsuji G, Ishii N, et al. Mucous membrane pemphigoid with antibodies to the beta(3) subunit of Laminin 332 in a patient with acute myeloblastic leukemia and graft-versus-host disease. Dermatology. 2009;219:361-4.
  9. Taylor J, McMillan R, Shephard M, et al. World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:161-71.e20. Rashid KA, Foster CS, Ahmed AR. Identification of Epitopes Within Integrin β4 for Binding of Auto-Antibodies in Ocular Cicatricial and Mucous Membrane Pemphigoid: Preliminary Report. Invest Ophthalmol Vis Sci. 2013;54:7707-16.
  10. Schmidt E, Spindler V, Eming R, et al. Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016. J Invest Dermatol. 2017;137:1199-203.
  11. Arduino P, Broccoletti R, Carbone M, et al. (2017). Describing the gingival involvement in a sample of 182 Italian predominantly oral mucous membrane pemphigoid patients: A retrospective series. Med Oral Patol Oral Cir Bucal. 2017;22:e149-e152. Petruzzi M. Mucous membrane pemphigoid affecting the oral cavity: short review on etiopathogenesis, diagnosis and treatment. Immunopharmacol Immunotoxicol. 2012;34:363-7.
  12. Xu H-H, Werth VP, Parisi E, et al. Mucous membrane pemphigoid. Dent Clin North Am. 2013;57:611-30.
  13. Jascholt I, Lai O, Zillikens D,